Evidence map›Paper›PMID 33513837›Full record

ArticleMolecules (Basel, Switzerland)2021

Microwave-Assisted Synthesis of (Piperidin-1-yl)quinolin-3-yl)methylene)hydrazinecarbothioamides as Potent Inhibitors of Cholinesterases: A Biochemical and In Silico Approach.

Rubina Munir, Muhammad Zia-Ur-Rehman, Shahzad Murtaza, Sumera Zaib, Noman Javid, Sana Javaid Awan, Kiran Iftikhar, Muhammad Makshoof Athar, Imtiaz Khan

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Royal Society open science · 2023
    Article
  5. Article
  6. (Molecules (Basel, Switzerland) · 2023
    Article
  7. Article
  8. Review
  9. Identification of Cyclic Sulfonamides with anPharmaceuticals (Basel, Switzerland) · 2022
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 2 countries.

Rubina MunirInstitute of Chemistry, University of the Punjab, Lahore 54590, Pakistan.ORCID 0000-0001-8015-5974
Muhammad Zia-Ur-RehmanApplied Chemistry Research Centre, PCSIR Laboratories Complex, Lahore 54600, Pakistan.
Shahzad MurtazaDepartment of Chemistry, University of Gujrat, Gujrat 50700, Pakistan.
Sumera ZaibDepartment of Biochemistry, Faculty of Life Sciences, University of Central Punjab, Lahore 54590, Pakistan.
Noman JavidInstitute of Chemistry, University of the Punjab, Lahore 54590, Pakistan.
Sana Javaid AwanInstitute of Molecular Biology and Biotechnology, The University of Lahore, Lahore 54000, Pakistan.
Kiran IftikharDepartment of Chemistry, University of Gujrat, Gujrat 50700, Pakistan.
Muhammad Makshoof AtharInstitute of Chemistry, University of the Punjab, Lahore 54590, Pakistan.
Imtiaz KhanDepartment of Chemistry and Manchester Institute of Biotechnology, The University of Manchester, 131 Princess Street, Manchester M1 7DN, UK.ORCID 0000-0001-7359-1727
University of the Punjab · PKUniversity of Gujrat · PKPakistan Council of Scientific & Industrial Research · PKUniversity of Central Punjab · PKUniversity of Lahore · PKUniversity of Manchester · GB

Funding

Higher Education Commision, Pakistan 12-33715-2PS1-501
6 · The paper itself

Abstract

Alzheimer's disease (AD), a progressive neurodegenerative disorder, characterized by central cognitive dysfunction, memory loss, and intellectual decline poses a major public health problem affecting millions of people around the globe. Despite several clinically approved drugs and development of anti-Alzheimer's heterocyclic structural leads, the treatment of AD requires safer hybrid therapeutics with characteristic structural and biochemical properties. In this endeavor, we herein report a microwave-assisted synthesis of a library of quinoline thiosemicarbazones endowed with a piperidine moiety, achieved via the condensation of 6/8-methyl-2-(piperidin-1-yl)quinoline-3-carbaldehydes and (un)substituted thiosemicarbazides. The target

Indexed as

AcetylcholinesteraseAlzheimer DiseaseButyrylcholinesteraseCell Line, TumorCell ProliferationCholinesterase InhibitorsCholinesterasesHep G2 CellsHeterocyclic CompoundsHumansHydrazinesMicrowavesMolecular Docking SimulationQuinolinesStructure-Activity RelationshipThioamidesAcetylcholinesteraseButyrylcholinesteraseCholinesterase InhibitorsCholinesterasesHeterocyclic CompoundshydrazinecarbothioamideHydrazinesquinolineQuinolinesThioamidesADME propertiesAlzheimer’s diseasecarbothioamidecholinesterasesHYDE assessmentmolecular dockingneurodegenerationpiperidinequinolinethiosemicarbazone

Identifiers

PMID33513837
PMCPMC7866225
OpenAlexW3123640346

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.